Literature DB >> 21757529

The globe and orbit in Laron syndrome.

L Kornreich1, O Konen, P Lilos, Z Laron.   

Abstract

BACKGROUND AND
PURPOSE: Patients with LS have an inborn growth hormone resistance, resulting in failure to generate IGF-1. The purpose of this study was to evaluate the size of the eye and orbit in LS.
MATERIALS AND METHODS: We retrospectively reviewed the MR imaging of the brain in 9 patients with LS for the following parameters: axial diameter of the globe, interzygomatic distance, perpendicular distance from the interzygomatic line to margins of the globe, medial-to-lateral diameter of the orbit at the anterior orbital rim, distance from the anterior orbital rim to the anterior globe, maximal distance between the medial walls of the orbits, lateral orbital wall angle, lateral orbital wall length, and mediolateral thickness of the intraorbital fat in the most cranial image of the orbit. All measurements were made bilaterally. Twenty patients referred for MR imaging for unrelated reasons served as control subjects.
RESULTS: Compared with the control group, the patients with LS had a significantly smaller maximal globe diameter and shallower but wider orbits due to a shorter lateral wall, a smaller medial distance between the orbits, and a larger angle of the orbit. The ratio between the most anterior orbital diameter and the globe was greater than that in controls. The position of the globe was more anterior in relation to the interzygomatic line.
CONCLUSIONS: Shallow and wide orbits and small globes relative to orbital size are seen in LS and may be secondary to IGF-1 deficiency.

Entities:  

Mesh:

Year:  2011        PMID: 21757529      PMCID: PMC7964357          DOI: 10.3174/ajnr.A2573

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  Craniofacial skeletal measurements based on computed tomography: Part II. Normal values and growth trends.

Authors:  A A Waitzman; J C Posnick; D C Armstrong; G E Pron
Journal:  Cleft Palate Craniofac J       Date:  1992-03

2.  Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome.

Authors:  Dan Haim Bourla; Zvi Laron; Moshe Snir; Pearl Lilos; Dov Weinberger; Ruth Axer-Siegel
Journal:  Ophthalmology       Date:  2006-07       Impact factor: 12.079

3.  Congenital growth hormone deficiency and eye refraction: a longitudinal study.

Authors:  Fulvio Parentin; Paolo Perissutti
Journal:  Ophthalmologica       Date:  2005 Jul-Aug       Impact factor: 3.250

4.  Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity).

Authors:  L Kornreich; G Horev; M Schwarz; B Karmazyn; Z Laron
Journal:  Eur J Endocrinol       Date:  2002-04       Impact factor: 6.664

5.  Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis.

Authors:  R G Peyster; F Ginsberg; J H Silber; L P Adler
Journal:  AJR Am J Roentgenol       Date:  1986-03       Impact factor: 3.959

6.  Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone--a Roentgenologic study.

Authors:  A Scharf; Z Laron
Journal:  Horm Metab Res       Date:  1972-03       Impact factor: 2.936

7.  Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment.

Authors:  Z Laron; B Klinger
Journal:  Horm Res       Date:  1993

8.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003.

Authors:  Zvi Laron
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  Refractive evaluation in children with growth defect.

Authors:  Fulvio Parentin; Giorgio Tonini; Paolo Perissutti
Journal:  Curr Eye Res       Date:  2004-01       Impact factor: 2.424

10.  Growth hormone receptor deficiency in Ecuador: clinical and biochemical phenotype in two populations.

Authors:  J Guevara-Aguirre; A L Rosenbloom; P J Fielder; F B Diamond; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

View more
  1 in total

1.  Growth Hormone Influence on the Morphology and Size of the Mouse Meibomian Gland.

Authors:  Yang Liu; Erich Knop; Nadja Knop; David A Sullivan; Edward O List; John J Kopchick; Wendy R Kam; Juan Ding
Journal:  J Ophthalmol       Date:  2016-02-14       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.